Gene: LMBRD1
Official Full Name: LMBR1 domain containing 1provided by HGNC
Gene Summary: This gene encodes a lysosomal membrane protein that may be involved in the transport and metabolism of cobalamin. This protein also interacts with the large form of the hepatitis delta antigen and may be required for the nucleocytoplasmic shuttling of the hepatitis delta virus. Mutations in this gene are associated with the vitamin B12 metabolism disorder termed, homocystinuria-megaloblastic anemia complementation type F.[provided by RefSeq, Oct 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO00326 | LMBRD1 Knockout cell line (HeLa) | Human | LMBRD1 | 1:3~1:6 | Negative | Online Inquiry |
KO20335 | LMBRD1 Knockout cell line (HCT 116) | Human | LMBRD1 | 1:2~1:4 | Negative | Online Inquiry |
KO20336 | LMBRD1 Knockout cell line (HEK293) | Human | LMBRD1 | 1:3~1:6 | Negative | Online Inquiry |
KO20337 | LMBRD1 Knockout cell line (A549) | Human | LMBRD1 | 1:3~1:4 | Negative | Online Inquiry |
LMBRD1 Gene Knockout Cell Lines are genetically modified cell lines that have been designed to provide a powerful tool for studying the specific roles of the LMBRD1 gene in cellular processes. The LMBRD1 gene, which encodes a protein involved in the cellular import of vitamin B12, has implications in various physiological pathways, including metabolism and cellular signaling. These knockout cell lines are created using the CRISPR-Cas9 gene-editing technology, effectively disrupting the LMBRD1 gene expression, allowing researchers to investigate the functional consequences of its absence.
The primary function of LMBRD1 knockout cell lines is to facilitate research into metabolic disorders associated with vitamin B12 deficiency and to explore the gene's potential involvement in other pathophysiological conditions. By employing these cell lines, scientists can elucidate the biochemical and molecular mechanisms modulated by LMBRD1, enabling a deeper understanding of its role in homeostasis and disease states. Additionally, LMBRD1 knockout cell lines serve as a basis for drug discovery and therapeutic interventions, particularly for disorders tied to cellular nutrient transport.
These knockout cell lines offer distinct advantages over traditional models, including precise gene editing, reproducibility, and the ability to manipulate cellular environments. Unlike other methods that may exhibit off-target effects, CRISPR-based knockouts provide a higher specificity, allowing for reliable results. This resolution is particularly crucial for researchers focused on developing targeted molecular therapies.
The value of LMBRD1 knockout cell lines extends to both academic and clinical researchers, providing them with the necessary tools to advance translational research and improve therapeutic outcomes. By utilizing these advanced cell lines, researchers can contribute to the broader understanding of nutrient transport mechanisms and their implications in health and disease.
Our company specializes in cutting-edge genetic engineering and cell line development, ensuring that our products meet the highest standards of quality and scientific integrity. We are committed to supporting innovative research that paves the way for medical breakthroughs and improved patient care.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.